PIEZO1 and prostate carcinoma: Piezo1 has been shown to sensitize PC3 prostate cancer cells to TRAIL via the intrinsic apoptotic pathway, where Ca2+ activates calpain via Piezo1, subsequently amplifying death-inducing signals in the TRAIL-mediated apoptotic pathway (Knoblauch et al., 2023).